Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Halotestin and Tamoxifen Interaction: Avoid | Peptide Database

Compound Profiles Halotestin Oral Anabolic Steroid | Extreme Strength & Aggression Fluoxymesterone exerts its effects primarily through exceptionally strong binding to the androgen receptor (AR), driven by its 9-alpha-fluoro and 11-beta-hydroxyl structural mod

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Halotestin

Oral Anabolic Steroid | Extreme Strength & Aggression

Fluoxymesterone exerts its effects primarily through exceptionally strong binding to the androgen receptor (AR), driven by its 9-alpha-fluoro and 11-beta-hydroxyl structural modifications that dramatically enhance receptor affinity beyond that of testosterone or DHT. Despite its extreme androgenic potency, it does not convert to estrogen via the aromatase enzyme, and its direct anabolic effect on skeletal muscle tissue is disproportionately low relative to its androgenic rating, likely due to rapid inactivation in muscle tissue.

Tamoxifen

Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment

Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Halotestin with Tamoxifen?

Combining Halotestin with Tamoxifen is not recommended. Both Halotestin and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Halotestin and Tamoxifen safe together?

This combination carries significant risk. Both Halotestin and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Halotestin and Tamoxifen?

Both Halotestin and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Halotestin and Tamoxifen?

Halotestin has a half-life of ~9.5 hours and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

GLORY-2 demonstrated 20.1% weight loss with 9mg over 60 weeks; 48.7% achieved ≥20% reduction. Significant reductions in waist circumference, systolic BP (-7.57 mmHg), triglycerides (-43%). Exploratory analysis showed 80.2% reduction in liver fat, suggesting MASLD/MASH benefits. HbA1c reductions of 1.41-2.03% across trials; DREAMS-3 showed -2.03% vs semaglutide -1.84%. 48% achieved HbA1c <7.0% AND ≥10% weight loss versus 21% with semaglutide. Systolic reduction of -7.57 mmHg, diastolic -2.98 mmHg in clinical trials. Total cholesterol -16.82%, triglycerides -43.29%, LDL -17.07%.

Source: peptide-db.com ↗

The Peptide Tier: Research Frontier

Standard supplements work through the gut. They’re absorbed, metabolised, and whatever reaches your mitochondria has been diluted along the way. Peptides bypass that. They’re injected directly into the bloodstream and reach mitochondria at therapeutic concentrations. Two peptides are specifically designed for mitochondrial function. Neither is FDA-approved. Both have stronger mechanistic data than most oral supplements.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Standard administration route; allows precise dosing and rapid hormone stimulation. Gonadotropin stimulation 100-200mcg Single dose or 2-3x weekly SubQ Fertility support 0.4-1.0 nmol/kg (50-150mcg) As directed by physician SubQ (KP-54) Sexual function (clinical) 1 nmol/kg/h 75-minute IV infusion IV infusion

Source: peptide-db.com ↗
Side effects

Common Side Effects

Dizziness or lightheadedness, particularly during the first few days or after dose increases Mild hypotension, especially in volume-depleted individuals or those on concurrent antihypertensives Upper respiratory tract infection symptoms (sinusitis, pharyngitis) - reported in clinical trials at rates similar to placebo Back pain and myalgia (uncommon but reported) Fatigue

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides